MedTrace Logo

Increasing the Number of Patients Receiving Information About Transition to End-of-life Care

NCT02091622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1431

Last updated 2014-03-19

No results posted yet for this study

Summary

Introduction: Honest prognostication and information for patients are important parts of end-of-life care. This study examined whether an educational intervention could increase the proportion of patients who received information about the transition to end-of-life care (ITEOL).

Method: Two municipalities (in charge of nursing homes) and two hospitals were randomized to receive an interactive half-day course about ITEOL for physicians and nurses. The proportion of patients who received ITEOL was measured with data from the Swedish Register of Palliative Care (SRPC). Patients were only included if they died an expected death and maintained their ability to express their will until days or hours before their death. Four hospitals and four municipalities were assigned controls, matched by hospital size, population, and proportion of patients receiving ITEOL at baseline.

Conditions

  • Palliative Care
  • Disclosure

Interventions

OTHER

Educative intervention

Two municipalities (in charge of nursing homes) and two hospitals were randomized to receive an interactive half-day course about ITEOL for physicians and nurses.

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Bertil Axelsson, MD PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02091622 on ClinicalTrials.gov